top of page

Peg Religrast 6 mg Injection

SKU Reliance Life Sciences Pvt Ltd
Prix d’origine

48,42$

Prix promotionnel

27,19$

Peg Religrast 6 mg Injection is a vital prescription medication designed to reduce the risk of infections in patients undergoing cancer therapies. This innovative treatment enhances the production of white blood cells, which are essential for a robust immune response, thereby offering protection against infections that can arise due to low white blood cell counts. Additionally, Peg Religrast may be beneficial for individuals exposed to significant radiation levels, assisting in their recovery by stimulating white blood cell regeneration. It's crucial to note that while Peg Religrast is effective, patients should be aware of potential side effects and consult their healthcare provider to understand the risks and benefits before starting treatment. This injection is administered under medical supervision, ensuring that patients receive the appropriate care during their recovery journey. With its targeted action, Peg Religrast not only helps strengthen the immune system but also supports overall health during challenging times, making it an essential part of cancer treatment protocols. Always discuss your medical history and any current medications with your healthcare professional to ensure the safe use of Peg Religrast.

Quantité

Active Pharmaceutical Ingredient

Pegfilgrastim 6 mg

Uses

• Peg religrast 6 mg injection is primarily used to reduce the risk of infections in patients undergoing chemotherapy. Chemotherapy can compromise the immune system, making patients more susceptible to infections. By administering Peg religrast, healthcare providers can help boost white blood cell production. This increase in white blood cells aids in protecting patients during their treatment.
• In addition to preventing infections, Peg religrast 6 mg injection can assist in managing neutropenia, a condition characterized by low levels of neutrophils. Neutrophils are essential for fighting off infections, and their depletion often occurs after chemotherapy. By using Peg religrast, clinicians can facilitate a quicker recovery of neutrophil counts. This ensures that patients remain better protected against potential infections during their vulnerable treatment phase.
• Peg religrast 6 mg injection may also be beneficial for patients with specific types of cancer that require intensive chemotherapy regimens. These regimens can severely impact bone marrow function, leading to a significant drop in white blood cells. By incorporating Peg religrast into the treatment plan, healthcare providers aim to maintain a healthier blood cell count. This strategy allows patients to continue their chemotherapy with a reduced risk of complications.
• Furthermore, Peg religrast 6 mg injection is often utilized in outpatient settings, allowing patients to receive treatment while minimizing hospital visits. This can be particularly advantageous for those who are undergoing multiple cycles of chemotherapy. By effectively managing their white blood cell levels, Peg religrast helps patients maintain a more favorable treatment schedule. This convenience supports both the patient's quality of life and treatment adherence.

Benefits

Peg Religrast 6 mg works by stimulating your body's immune system to increase the production of white blood cells. The cells that help us fight infections are called white blood cells. You must use this medicine under medical supervision to make it really effective. To help prevent infections, avoid being in crowded places and wash your hands often. Drink plenty of fluids, unless you are told otherwise by your doctor or health care professional.

Side Effects

Peg Religrast 6 mg Injection adverse effects can vary depending on various factors. Some of the common and severe adverse effects are listed below.

Most Common Side Effects

• Dizziness
• Headache
• Appetite Loss
• Constipation
• Infection in the Urinary and Respiratory Tract
• Hair Loss
• Low Count of Red Blood cells
• Fluctuation in the Blood Pressure
• Diarrhoea
• Dizziness
• Nose Bleeds
• Tingling in Feet and hands
• Chest Pain
• Pain during Urination

Common Side Effects

• Rashes
• Headache
• Nausea
• Bone pain
• Leg pain

How To Use

Peg Religrast Injection is given through intravenous infusion by your doctor or nurse. Follow the guidelines of the doctor carefully during the treatment. Please do not self-administer this Peg Religrast 6 mg.

Safety Advice

• Alcohol: It is not known whether it is safe to drink alcohol with Peg Religrast Injection. Consult your medical doctor for advice.
• Kidney: Peg Religrast 6 mg Injection is safe to use in patients with kidney disease. No dose change is recommended in patients with kidney impairment, including those with end-stage kidney disease.
• Breastfeeding: Peg Religrast 6 mg Injection should not be given to lactating women. There is no clinical experience with nursing women.
• Liver: There is only a limited amount of information available on the use of Peg Religrast 6 mg Injection in patients with liver disease. Consult your medical doctor for advice.
• Pregnancy: Peg Religrast 6 mg Injection is not recommended during pregnancy or in women who may become pregnant and are not using contraceptives. There are no data available on the use of Peg Religrast 6 mg Injection in pregnant women. Studies in animals have shown toxicity to the reproductive system. The potential risk to the human embryo or fetus is not known.
• Driving: Peg Religrast 6 mg has no or negligible effects on the ability to drive or to use machines.

bottom of page